Twist Bioscience Corporation 0ME.F Stock
Twist Bioscience Corporation Price Chart
Twist Bioscience Corporation 0ME.F Financial and Trading Overview
| Twist Bioscience Corporation stock price | 29.95 EUR |
| Previous Close | 16.71 EUR |
| Open | 16.82 EUR |
| Bid | 16.84 EUR x 10000 |
| Ask | 17.51 EUR x 10000 |
| Day's Range | 16.82 - 16.82 EUR |
| 52 Week Range | 10.24 - 55.07 EUR |
| Volume | 5 EUR |
| Avg. Volume | 7 EUR |
| Market Cap | 975.54M EUR |
| Beta (5Y Monthly) | 1.150421 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.37 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 120.86 EUR |
0ME.F Valuation Measures
| Enterprise Value | 658.49M EUR |
| Trailing P/E | N/A |
| Forward P/E | -5.3738017 |
| PEG Ratio (5 yr expected) | -0.25 |
| Price/Sales (ttm) | 4.2816315 |
| Price/Book (mrq) | 1.3644844 |
| Enterprise Value/Revenue | 2.89 |
| Enterprise Value/EBITDA | -3.109 |
Trading Information
Twist Bioscience Corporation Stock Price History
| Beta (5Y Monthly) | 1.150421 |
| 52-Week Change | -39.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 55.07 EUR |
| 52 Week Low | 10.24 EUR |
| 50-Day Moving Average | 12.73 EUR |
| 200-Day Moving Average | 24.43 EUR |
0ME.F Share Statistics
| Avg. Volume (3 month) | 7 EUR |
| Avg. Daily Volume (10-Days) | 15 EUR |
| Shares Outstanding | 57.15M |
| Float | 56.42M |
| Short Ratio | N/A |
| % Held by Insiders | 1.43% |
| % Held by Institutions | 109.35% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -93.31% |
| Operating Margin (ttm) | -102.49% |
| Gross Margin | 41.33% |
| EBITDA Margin | -92.96% |
Management Effectiveness
| Return on Assets (ttm) | -15.56% |
| Return on Equity (ttm) | -27.13% |
Income Statement
| Revenue (ttm) | 227.84M EUR |
| Revenue Per Share (ttm) | 4.04 EUR |
| Quarterly Revenue Growth (yoy) | 25.00% |
| Gross Profit (ttm) | 84.24M EUR |
| EBITDA | -211820992 EUR |
| Net Income Avi to Common (ttm) | -212612000 EUR |
| Diluted EPS (ttm) | -3.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 387.66M EUR |
| Total Cash Per Share (mrq) | 6.78 EUR |
| Total Debt (mrq) | 91.22M EUR |
| Total Debt/Equity (mrq) | 12.96 EUR |
| Current Ratio (mrq) | 6.785 |
| Book Value Per Share (mrq) | 12.327 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -133750000 EUR |
| Levered Free Cash Flow (ttm) | -178064752 EUR |
Profile of Twist Bioscience Corporation
| Country | Germany |
| State | CA |
| City | South San Francisco |
| Address | 681 Gateway Boulevard |
| ZIP | 94080 |
| Phone | 800 719 0671 |
| Website | https://www.twistbioscience.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 810 |
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Q&A For Twist Bioscience Corporation Stock
What is a current 0ME.F stock price?
Twist Bioscience Corporation 0ME.F stock price today per share is 29.95 EUR.
How to purchase Twist Bioscience Corporation stock?
You can buy 0ME.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Twist Bioscience Corporation?
The stock symbol or ticker of Twist Bioscience Corporation is 0ME.F.
Which industry does the Twist Bioscience Corporation company belong to?
The Twist Bioscience Corporation industry is Diagnostics & Research.
How many shares does Twist Bioscience Corporation have in circulation?
The max supply of Twist Bioscience Corporation shares is 57.82M.
What is Twist Bioscience Corporation Price to Earnings Ratio (PE Ratio)?
Twist Bioscience Corporation PE Ratio is now.
What was Twist Bioscience Corporation earnings per share over the trailing 12 months (TTM)?
Twist Bioscience Corporation EPS is -3.37 EUR over the trailing 12 months.
Which sector does the Twist Bioscience Corporation company belong to?
The Twist Bioscience Corporation sector is Healthcare.